Proactive MD selects health care industry leader Dr. Saria Saccocio as company president
With a history of leading award-winning programs and improving the coordination and quality of care, Saccocio is passionate about helping...
Day: October 19, 2021
First Patient Dosed in Phase IIa DMT-Assisted Therapy Clinical Trial
Phase IIa to explore the effectiveness of DMT in combination with psychotherapy for the potential treatment of Major Depressive Disorder...
Virbac : Declaration of the number of shares and voting rights 09/2021
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information...
Statera Biopharma, Inc. Announces Institutional Review Board Approves Study of STAT-205 for Acute COVID-19
Researchers at Loma Linda University Health to Evaluate Pharmacokinetics, Biomarkers and Safety of STAT-205 FORT COLLINS, Colo., Oct. 19, 2021...
Locus Biosciences Secures Financing of up to $25 Million from Hercules Capital
Proceeds to be used to advance development of synthetic biology engine and manufacturing capabilitiesRESEARCH TRIANGLE PARK, N.C., Oct. 19, 2021...
Plus Therapeutics Announces FDA Clearance of Investigational New Drug Application for 186RNL for the Treatment of Leptomeningeal Metastases
Patient accrual for the Phase 1 dose escalation clinical trial of 186RNL (ReSPECT-LM) is expected in the fourth quarter of...
Progenity to Participate in Crohn’s & Colitis Foundation’s Fourth Annual IBD Innovate Conference
SAN DIEGO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the...
Venus Concept Receives FDA 510(k) Clearance for the Venus Freedom™
TORONTO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
KemPharm, Inc. Announces Uplisting to The Nasdaq Global Select Market
Trading to commence effective with the open of business on October 19, 2021 CELEBRATION, Fla., Oct. 19, 2021 (GLOBE NEWSWIRE)...
Antios Therapeutics and Assembly Biosciences Announce Clinical Collaboration Agreement to Evaluate the Combination of ATI-2173 and Vebicorvir in Patients with Chronic Hepatitis B Virus Infection
MENDHAM, N.J., and SOUTH SAN FRANCISCO, Calif, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Antios Therapeutics, Inc. and Assembly Biosciences, Inc....
Rapid Micro to Announce Third Quarter 2021 Financial Results on November 11, 2021
Conference Call to Discuss Results on November 12, 2021 at 5:00am Pacific Time/8:00am Eastern TimeLOWELL, Mass., Oct. 19, 2021 (GLOBE...
InflaRx Awarded up to EUR 43.7 Million (~USD 50.7 Million) Grant by German Government to Advance the Development of Vilobelimab for Treatment of Severe COVID-19
Initial portion of the grant amounts to EUR 25.8 millionRemainder of the grant will be awarded in three additional milestone-dependent...
Artizan Biosciences Announces Appointment of Dr. Bridget Martell as President and Chief Executive Officer
Artizan Biosciences, Inc. Bridget Martell, M.A., M.D., President and Chief Executive Officer, Artizan Biosciences, Inc. NEW HAVEN, Conn., Oct. 19,...
AIM ImmunoTech Submits IND and Accompanying Fast Track Application for Phase 2 Trial of Ampligen in Patients with Locally Advanced or Metastatic Late-Stage Pancreatic Cancer
OCALA, Fla., Oct. 19, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has submitted...
Challenge Testing of Kraig Biocraft Laboratories’ Disease Resistant Silkworms Underway
Immunity enhanced silkworms provide licensing opportunities into the broader $14B1 silk industry ANN ARBOR, Mich., Oct. 19, 2021 (GLOBE NEWSWIRE)...
uniQure Announces Presentations at the Annual Meeting of The European Society of Gene and Cell Therapy (ESGCT)
Oral Presentation to Highlight AMT-191 for Fabry DiseaseLEXINGTON, Mass. and AMSTERDAM, The Netherlands, Oct. 19, 2021 (GLOBE NEWSWIRE) -- uniQure...
Oxford Biomedica Announces that Boehringer Ingelheim has Exercised Option Relating to a Novel Gene Therapy Treatment for Cystic Fibrosis
Oxford Biomedica Announces that Boehringer Ingelheim has Exercised Option Relating to a Novel Gene Therapy Treatment for Cystic Fibrosis Oxford,...
Inivata Announces Clinical Collaboration with Princess Margaret Cancer Center for the use of its Liquid Biopsy Assays
Inivata Announces Clinical Collaboration with Princess Margaret Cancer Center for the use of its Liquid Biopsy Assays Two clinical studies...
Amryt Announces New Patents for Oleogel-S10 and Mycapssa®
Amryt Announces New Patents for Oleogel-S10 and Mycapssa® DUBLIN, Ireland, and Boston MA, October 19, 2021, Amryt (Nasdaq: AMYT, AIM:...
COMPASS Pathways is granted new US patent for crystalline psilocybin
London, UK – 19 October 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating...
